Tell Patients to Stop Laxatives When Starting Movantik

Movantik (mo-VAN-tick, naloxegol) will be a new ORAL opioid antagonist for treating opioid-induced constipation.

Think of it as an option for patients who don't respond to osmotic laxatives (polyethylene glycol, etc) or stimulants (bisacodyl, etc).

It blocks the effects of opioids in the gut...similar to Relistor (methylnaltrexone). Both lead to about one more bowel movement/week.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote